1. Acute Ischemic Stroke Treatment Industry Analysis Report 2023: Covering Key Segments and Share Analysis: https://report.csdn.net/market/653ddd4691098a10412740c1.html (accessed on May 23, 2024).
2.
Berge E, Whiteley W, Audebert H, De Marchis GM, Fonseca AC, Padiglioni C, de la Ossa NP, Strbian D, Tsivgoulis G, Turc G. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J 2021; 6: I-LXII.
3.
Cai H, Ma Y, Jiang L, Mu Z, Jiang Z, Chen X, Wang Y, Yang GY, Zhang Z. Hypoxia response element-regulated MMP-9 promotes neurological recovery via glial scar degradation and angiogenesis in delayed stroke. Mol Ther 2017; 25: 1448-1459.
4.
Chen BW, Xu YQ, Tang RM, Yi J, Liu BY. Exploring the protective mechanism of Buyang Huanwu Decoction on the neurovascular unit in rats with cerebral ischemia based on miRNA microarray. Tradit Chin Drug Res Clinl Pharmacol 2022; 33: 333-341.
5.
Ding S, Wang C, Wang W, Yu H, Chen B, Liu L, Zhang M, Lang Y. Autocrine S100B in astrocytes promotes VEGF-dependent inflammation and oxidative stress and causes impaired neuroprotection. Cell Biol Toxicol 2023; 39: 1-25.
6.
Garcia-Alix A, Arnaez J. Neuron-specific enolase in cerebrospinal fluid as a biomarker of brain damage in infants with hypoxic-ischemic encephalopathy. Neural Regen Res 2022; 17: 318-319.
7.
Hanin A, Denis JA, Frazzini V, Cousyn L, Imbert-Bismut F, Rucheton B, Bonnefont-Rousselot D, Marois C, Lambrecq V, Demeret S, Navarro V. Neuron specific enolase, S100-beta protein and progranulin as diagnostic biomarkers of status epilepticus. J Neurol 2022; 269: 3752-3760.
8.
Khandare P, Saluja A, Solanki RS, Singh R, Vani K, Garg D, Dhamija RK. Serum S100B and NSE levels correlate with infarct size and bladder-bowel involvement among acute ischemic stroke patients. J Neurosci Rural Pract 2022; 13: 218-225.
9.
Kurakina AS, Semenova TN, Guzanova EV, Nesterova VN, Schelchkova NA, Mukhina IV, Grigoryeva VN. Prognostic value of investigating neuron-specific enolase in patients with ischemic stroke. Sovrem Tekhnologii Med 2021; 13: 68-72.
10.
Lei Y, Chen X, Mo JL, Lv LL, Kou ZW, Sun FY. Vascular endothelial growth factor promotes transdifferentiation of astrocytes into neurons via activation of the MAPK/Erk-Pax6 signal pathway. Glia 2023; 71: 1648-1666.
11.
Li S, Zhan M, Yan S, Xiao X. The antifatigue mechanism of Buyang-huanwu Decoction as revealed by serum metabolomics in an endurance swimming rat model. J Med Food 2022; 25: 1038-1049.
12.
Li X, Song Y, Yang Y, Zhang G. Buyang Huanwu Decoction promotes the neurological recovery of traumatic spinal cord injury via inhibiting apoptosis, inflammation, and oxidative stress. Immun Inflamm Dis 2023; 11: e933.
13.
Liang S, Wu Y, Zhang R, Xin X, Xu L. Therapeutic effects of Buyang Huanwu Tang combined with RT-PA intravenous thrombolysis on stroke of Qi deficiency and blood stasis type and its impact on Keap1-Nrf2/ARE pathway antioxidant stress. Cell Mol Biol (Noisy-le-grand) 2023; 69: 210-216.
14.
Ministry of Health of the People’s Republic of China. Guideline for Clinical Trials of New Patent Chinese Medicines. China Medical Science and Technology Press, Beijing 2002; 101-106.
15.
Moon S, Chang MS, Koh SH, Choi YK. Repair mechanisms of the neurovascular unit after ischemic stroke with a focus on VEGF. Int J Mol Sci 2021; 22: 8543.
16.
Onatsu J, Vanninen R, Jäkälä P, Mustonen P, Pulkki K, Korhonen M, Hedman M, HÖglund K, Blennow K, Zetterberg H, Herukka SK, Taina M. Tau, S100B and NSE as blood biomarkers in acute cerebrovascular events. In Vivo 2020; 34: 2577-2586.
17.
Paul S, Candelario-Jalil E. Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies. Exp Neurol 2021; 335: 113518.
18.
Ryu HH, Kang JC, Namgung U, Kim SY, Park JY. Anti-inflammatory effects of modified Buyang Huanwu Decoction. Evid Based Complement Alternat Med 2020; 2020: 6458460.
19.
She Y, Shao L, Jiao K, Sun R, Lang T, Long H, Tang Y, Zhang W, Ding C, Deng C. Glycosides of Buyang Huanwu decoction inhibits pyroptosis associated with cerebral ischemia-reperfusion through Nrf2-mediated antioxidant signaling pathway both in vivo and in vitro. Phytomedicine 2023; 120: 155001.
20.
Song HZ, Rao JP, Luo LY. Study on the relationship between serum S100b protein and condition and prognosis in patients with acute cerebral infarction after intravenous thrombolysis. Jilin Med J 2022; 43: 589-593.
21.
Stroke Prevention and Treatment Engineering Committee of National Health Commission, Neurological Intervention Group of Neurosurgery Branch of Chinese Medical Association, Intervention Group of Radiology Branch of Chinese Medical Association, et al. Chinese expert consensus statement on endovascular therapy in ischemic stroke with acute large-vessel occlusion (2017 revised). Chin J Neurosurg 2017; 33: 869-877.
22.
Sun H, Wu C. Acupuncture combined with Buyang Huanwu decoction in treatment of patients with ischemic stroke. J Int Med Res 2019; 47: 1312-1318.
23.
The Fourth National Cerebrovascular Disease Conference. Criteria for scoring the degree of clinical neurological impairment in stroke patients (1995). Chin J Neurol 1996; 29: 381-382.
24.
Wang HJ, Ran HF, Yin Y, Xu XG, Jiang BX, Yu SQ, Chen YJ, Ren HJ, Feng S, Zhang JF, Chen Y, Xue Q, Xu XY. Catalpol improves impaired neurovascular unit in ischemic stroke rats via enhancing VEGF-PI3K/AKT and VEGF-MEK1/2/ERK1/2 signaling. Acta Pharmacol Sin 2022; 43: 1670-1685.
25.
Włodarczyk L, Cichoń N, Karbownik MS, Saso L, Saluk J, Miller E. Circulating serum VEGF, IGF-1 and MMP-9 and expression of their genes as potential prognostic markers of recovery in post-stroke rehabilitation – a prospective observational study. Brain Sci 2023; 13: 846.
26.
Xie X, Zhou XP, Fan J. Correlation between serum galectin-3, MMP-9 expression and neurological deficit after intravenous thrombolysis in patients with acute ischemic stroke. J Apop Nerv Dis 2022; 39: 719-722.
27.
Yao Y, Liu F, Gu Z, Wang J, Xu L, Yu Y, Cai J, Ren R. Emerging diagnostic markers and therapeutic targets in post-stroke hemorrhagic transformation and brain edema. Front Mol Neurosci 2023; 16: 1286351.
28.
Ze XY, An CX, Liu L, Tang SB. Changes of serum ADPN, S100-b protein, CRP/ALB in ACI patients and their predictive value for prognosis. Shandong Med J 2023; 63: 48-50.
29.
Zhang W, Han L, Wen Y, Su L, Li Y, Luo X. Electroacupuncture reverses endothelial cell death and promotes angiogenesis through the VEGF/Notch signaling pathway after focal cerebral ischemia-reperfusion injury. Brain Behav 2023; 13: e2912.
30.
Zheng XY, Zhang YH, Song WT, Cao H, Liu JX. Effects of Buyang Huanwu Decoction on neurovascular units after cerebral ischemia: a review. China J Chin Materia Medica 2021; 46: 5226-5232.
31.
Zheng YB, Wang W. Relationship of matrix metalloproteinase-9, inducible nitric oxide synthase, neuron-specific enolase, and neurodirective factor-1 with neurological deficits and prognosis in CIS patients. Mod Med Health Res 2023; 7: 93-96.
32.
Zhong D, Zhang ST, Wu B. Interpretation of “Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018”. Chin J Contemp Neurol Neurosurg 2019; 19: 897-901.
